Invitrogen Licenses IMBcom's Non-Coding RNAs

Jan 17, 2008

NEW YORK (GenomeWeb News) – Invitrogen announced today that it has licensed exclusive rights from Australian company IMBcom to commercialize new non-coding RNA molecules as they are developed.

Invitrogen said the agreement will expand its RNA product portfolio, and its NCode microRNA microarray product line in particular.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

When the Ailment You're Studying Becomes Personal

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

Irish Genomics Initiative Looks to Expand Into Scotland

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

Another Source of Data for 23andMe

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

This Week in PLOS

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Featured White Papers

How to Perform Successful CRISPR Experiments

High Throughput RT-qPCR for Gene Expression Analysis

May

08

Featured Webinar

Structural Variation Detection by Proximity Ligation from FFPE Tumor Tissue

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.

Main menu